Mural Oncology
MURA
MURA was delisted on the 4th of December, 2025.
101 hedge funds and large institutions have $59.9M invested in Mural Oncology in 2024 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 14 increasing their positions, 51 reducing their positions, and 38 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
8.27% less ownership
Funds ownership: 80.7% → 72.43% (-8.3%)
18% less funds holding
Funds holding: 123 → 101 (-22)
25% less capital invested
Capital invested by funds: $79.7M → $59.9M (-$19.8M)
58% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 38
73% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 51
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Solas Capital Management
Darien,
Connecticut
|
+$3.64M |
| 2 |
Verition Fund Management
Greenwich,
Connecticut
|
+$3.08M |
| 3 |
BBA
Baker Bros. Advisors
New York
|
+$1.08M |
| 4 |
Renaissance Technologies
New York
|
+$1.05M |
| 5 |
SGL
Sonic GP LLC
Honolulu,
Hawaii
|
+$811K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.76M |
| 2 |
Westfield Capital Management
Boston,
Massachusetts
|
-$2.12M |
| 3 |
Bank of New York Mellon
New York
|
-$1.67M |
| 4 |
Pictet Asset Management
Carouge,
Switzerland
|
-$1.67M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$1.1M |
MURA Hedge Fund Activity: Q1 2024 in Review
101 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Mural Oncology (MURA) for Q1 2024, worth a combined $59.9M — down 25% from $79.7M a quarter earlier.
Sellers outnumbered buyers: 38 funds closed out of MURA and 16 opened new positions — a net loss of 22 holders — while 51 trimmed existing stakes and 14 added.
The largest buyer was Solas Capital Management, opening a new position worth an estimated $3.64M. The largest seller was Vanguard Group, cutting an estimated $2.76M.
- 101 institutional investors held Mural Oncology (MURA) as of Q1 2024, down from 123 in Q4 2023.
- Funds reported $59.9M of Mural Oncology stock for Q1 2024, down 25% quarter-over-quarter.
- 16 funds opened new Mural Oncology positions in Q1 2024 and 38 closed out, a net change of -22 holders.
- The largest Mural Oncology buyer in Q1 2024 was Solas Capital Management, an estimated $3.64M added.
- The largest Mural Oncology seller in Q1 2024 was Vanguard Group, an estimated $2.76M sold.
Based on aggregated 13F filings for Q1 2024.